Table 3.
Overview of recurrent CGH findings in seven thyroid carcinoma cell lines
| Frequency | SRO | |
| Gains | ||
| 5p | 6/7 | 5p12p15 |
| 5q | 6/7 | 5q22q35 |
| 8q | 6/7 | 8q11q24 |
| 20q | 6/7 | 20q12q13 |
| 11p | 4/7 | 11p12p15 |
| 17q | 4/7 | 17q21q24 |
| Losses | ||
| 8p | 4/7 | 8p22p23 |
| 13q | 4/7 | 13q12q21 13q32q34 |
| 18q | 4/7 | 18q12q22 |
| Xp | 4/7 | Xp11p21 |
| Amp | ||
| 8q | 4/7 | 8q11q23 |
| 20q | 3/7 | 20q11q13 |
| 5p | 2/7 | 5p12p15 |
| 5q | 2/7 | 5q23q33 |
| 7pq | 2/7 | 7p22q36 |
| 20p | 2/7 | 20p11p13 |
For gains and losses, only regions seen in more than 3 cell lines are provided. Abbreviations: SRO, smallest region of overlap; Amp, amplifications.